CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-09 | ELMS STEVE Director | Grant or award · Stock Option (Right to Buy) | +17,730 | 17,730 | ||
| 2025-12-15 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,028,850 |
| 2025-12-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $19.79 | $297K | 2,013,850 |
| 2025-12-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $19.79 | $119K | 2,007,850 |
| 2025-12-15 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 720,950 | ||
| 2025-11-19 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,034,850 |
| 2025-11-19 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $16.00 | $240K | 2,019,850 |
| 2025-11-19 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $16.00 | $96K | 2,013,850 |
| 2025-11-19 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 735,950 | ||
| 2025-10-24 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,040,850 |
| 2025-10-24 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $16.00 | $240K | 2,025,850 |
| 2025-10-24 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $16.00 | $96K | 2,019,850 |
| 2025-10-24 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 750,950 | ||
| 2025-09-15 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,046,850 |
| 2025-09-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $16.13 | $242K | 2,031,850 |
| 2025-09-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $16.13 | $97K | 2,025,850 |
| 2025-09-15 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 765,950 | ||
| 2025-08-15 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,052,850 |
| 2025-08-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $16.88 | $253K | 2,037,850 |
| 2025-08-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $16.88 | $101K | 2,031,850 |
Page 4 of 31 · 618 trades